Unravelling interferon-α-induced responses of pancreatic α- and β-cells: an opportunity to seek for new therapeutic approaches for type 1 diabetes (Ministerio de Ciencia e Innovación: PID2020-117569RA-I00)

Unravelling interferon-α-induced responses of pancreatic α- and β-cells: an opportunity to seek for new therapeutic approaches for type 1 diabetes (Ministerio de Ciencia e Innovación: PID2020-117569RA-I00)

by | Sep 11, 2021 | Grant

T Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by pancreatic islet inflammation and specific destruction of insulin-producing beta-cells by the immune system. Intriguingly, neighbouring glucagon-secreting alpha-cells survive the autoimmune...

About Us

Our team is based at the Universidad Miguel Hernández de Elche and focuses on pancreatic islet function and survival in health and diabetes. Have a look through our site to learn more or write to us if you have any questions. We’ll be happy to help!

Contact Us

Ed. Torregaitán, Av. de la Universidad s/n, 03202, Elche, Spain.

+34 965 222 062

lmarroqui@umh.es

@isletbiologylab

 

Our Group

Unidad de Investigación Básica en Diabetes.

Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche.

Universidad Miguel Hernández de Elche.

This website has been created with funds of the SEJI Project, Generalitat Valenciana (SEJI/2018/023). © 2025 Universidad Miguel Hernández |  Designed with ❤️ by C. Sala Ripoll.